Bøker utgitt av American Psychiatric Association Publishing

"Well over 150 medications are represented in this new Handbook of Practical Psychopharmacology. Intended as a quick-reference tool for clinicians, trainees, and other practitioners, it is rich in high-yield, evidence-based, and easily accessible information for commonly prescribed psychopharmacological agents, including antidepressants, antipsychotics, stimulants, mood stabilizers, and nutraceuticals/phytoceuticals. For each medication covered, readers will find concise, easily referenced information on: * Indications * Contraindications * Dosing * Drug interactions * Clinical monitoring * Adverse effects Conveniently organized by drug class and indication, the handbook also features clinical pearls for each agent and class from experts and published literature in the field. Readers will benefit from evidence-based information on off-label prescribing, as well as from sections devoted to prescribing in special situations (e.g., pregnancy and lactation) and in specific populations (e.g., older adults and children/adolescents). As useful as a teaching tool and study guide as it is as an on-the-spot resource in outpatient, inpatient, and emergency settings, the Handbook of Practical Psychopharmacology is the busy practitioner's must-have companion"--

"This book primarily informs consumers of mental health services about the types of anxiety, depressive, and related disorders and their treatments. Beginning with how to find a physician who can provide the appropriate and effective clinical services, it goes on to discuss assessment, diagnosis, and treatment, as well as potential barriers to treatment, such as the lack of availability of a mental health professional nearby or financial costs. Diagnoses and their treatment among various populations, including males, females, children and adolescents, pregnant patients, and elderly patients are also addressed"--

Examines the many intersections between substance use disorders (SUDs) and the law-arrest, incarceration, and employment among them-helping readers navigate the overlap between the medical management of addictive disorders and the current legal framework. In four exhaustive sections, the book covers crucial issues in treating SUD patients.

"In Encountering Treatment Resistance, the author argues that patients must never be considered beyond aiding, given that second opinions identify additional treatment options in two-thirds of cases labeled treatment resistant. The book includes discussion of best practices for problem-solving and practical guidance on recognizing common but underappreciated medical causes of treatment failure and how to consistently achieve a thorough evaluation at each patient contact"--

"Schatzberg's Manual of Clinical Psychopharmacology is the leading resource for the clinical use of psychiatric medications. Now in its tenth edition, the manual offers thoroughly updated, exhaustively vetted evidence-based information on psychotropic medications that training and practicing clinicians will find useful and authoritative"--

"In Substance Use in Older Adults, more than 20 contributors translate their real-world experience in geriatric psychiatry into an accessible, evidence-based guide to screening for and assessing substance use in older adults. Early chapters discuss etiology and epidemiology, as well as comorbidities and management. Subsequent sections address the problematic use of specific substances, including alcohol, tobacco, opioids, sedatives, stimulants, and cannabinoids. Readers will find guidance on safe prescribing practices for older patients, as well as an examination of the cultural and ethical issues that may arise when working with this patient population. Full of case examples that illustrate key points in clinical practice, this book also features numerous tables with information on comorbidities, screening frameworks, and interventions for specific substances; stigma-reducing language; the pharmacological implications of physiological changes in older adults; and more. Clinicians from psychiatric professionals to primary care providers will benefit from exhaustive listings of additional resources. Importantly, this guide also includes resources for patients, families, and caregivers that will help to strengthen the partnership between clinician and patient"--

"The psychoanalytic frame, as we have known it, is at risk of disappearing. Psychoanalysts must meet the challenges of working within a radically altered psychoanalytic frame at a time of antiscientific attitudes toward climate change and heightened demands for racial justice and gender self-identification. We live in a frightening world in which psychoanalytic thinking might be of great assistance. Authors in this new edition explore how psychoanalysis is evolving in the current zeitgeist with its many challenges. All the chapters show that psychoanalytic methods, while recognizing the importance of the past, continue to remain open to the potential for new possibilities even in uncertain, extraordinary times. The search for individual truth has always been at the core of psychoanalytic thought. This third edition acknowledges the sociocultural and geopolitical forces that are shaping all our lives and affecting our search for truth, with the aim of sustaining that search"--

Explores the background of the Personality Inventory for DSM-5 (PID-5) and provides clinical and research guidance on its application. This is a concise, convenient, and indispensable resource for all those interested in an individualized approach to the management and treatment of personality pathologies.

"Now in its sixth edition, The American Psychiatric Association Publishing Textbook of Psychopharmacology remains the field's most comprehensive guide to the theory and practice of psychopharmacology. This extensively updated new edition features the expertise of more than 160 contributors, including more than 75 new authors. Twelve new chapters have been added to cover important key areas in this rapidly evolving specialty, including personalized medicine in psychiatry; the role of artificial intelligence and machine learning in the field; new agents with novel mechanisms, such as the neurosteroid antidepressant brexanolone and the atypical antipsychotic pimavanserin; use of investigational agents, such as psychedelics, in psychiatric treatment; evidence-based treatment of PTSD, OCD, autism spectrum disorder, and alcohol use disorder; and much more. Unrivaled in its rigor and relevance, The American Psychiatric Association Publishing Textbook of Psychopharmacology is an indispensable resource for all clinicians who prescribe psychotropic medications"--

"DSM-5-TR Self-Exam Questions: Test Questions for the Diagnostic Criteria elucidates the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision, through self-exam questions designed to test the reader's knowledge of the new edition's diagnostic criteria"--

"Of increasing importance in the field of psychiatry, epigenetics has led to a greater understanding of pathologies and their possible treatments. The more complex aspects of epigenetics-the study of cellular events that affect gene expression without changing the DNA sequence-often exceed the scope of preclinical training for many mental health providers. Applied Epigenetics for Mental Health Professionals contains the instructive material to close this gap"--

Integrating cutting-edge neuroscience, clinical research, evidence-based best practices, mental health systems design, and mental health policy, this is the first textbook in the field to provide an affirming, intersectional, and evidence-informed approach to caring for transgender, non-binary, and/or gender-expansive individuals.

"Pharmacotherapy for Complex Substance Use Disorders: A Practical Guide provides practical clinical pearls and evidence-based recommendations to help clinicians feel more confident in their management of patients with complex substance use disorders. Our team of addiction psychiatrists identified relatively limited literature on the pharmacotherapy of multisubstance use disorders and special patient populations such as adolescents, pregnant patients, and members of the LGBTQ community. With few FDA-approved treatments for substance use disorders and no explicit treatment guidelines, we hope to bring our clinical experience to mental health and primary care clinicians. Most of all, we hope to allay fears and instill hope in clinicians and patients during their recovery journeys"--

"The DSM-5-TR Handbook of Differential Diagnosis helps clinicians and students learning the process of psychiatric diagnosis to improve their skill in formulating a comprehensive differential diagnosis by providing a variety of approaches to consider symptomatic presentations. These include a six-step diagnostic framework of issues to consider for every patient, 30 decision trees and corresponding commentary to evaluate key presenting symptoms, and 67 differential diagnosis tables for use once a tentative diagnosis has been made, to ensure that all reasonable alternatives have received adequate consideration. Appendixes to this handbook include the DSM-5-TR Classification, to facilitate coding and to provide an overview of all the DSM-5-TR diagnoses that must be considered, as well as alphabetical indexes of the decision trees and differential diagnosis tables"--

Many contemporary researchers have defined emerging adulthood as the period between ages 18 and 29 years, but this new volume argues that it is more useful to look at early emerging adulthood, or late adolescence (ages 18-23), and later emerging adulthood (ages 24-29) separately.

Provides both clinical and non-clinical readers with a science-based approach to identifying and addressing prolonged grief disorder, along with what might be termed 'normal' grief.

A question-and-answer companion that allows you to evaluate your mastery of the subject matter as you progress through Dulcan's Textbook of Child and Adolescent Psychiatry, Third Edition. The Study Guide is made up of approximately 295 questions divided into 49 individual quizzes of 5-8 questions.

More than four decades of perspectives from the American Psychiatric Association's Solomon Carter Fuller Award lectures are collected in this seminal anthology. The chapter authors provide a multidisciplinary, cross-sectional examination of the historical, current, and future societal context that informs the Black experience in the United States.

Updated to include a thorough review of the most recent evidence-based information and data-driven best treatment practices in child psychiatry, this fourth edition examines the evidence for treating mental health disorders in younger patients and illuminates the difference between methodological approaches in a variety of clinical trials.

When prescribed appropriately, most psychotropic medications are fairly safe. Although some side effects are common and even expected, occasional serious - and even life-threatening - adverse effects may arise that require immediate intervention. This volume focuses on the latter.

Gathers the literature and treatment guidance materials related to delusions in one place to offer clinicians an up-to-date, culturally informed, and illustrated guide to managing the spectrum of delusions and other extreme beliefs encountered in daily practice.

Seamlessly combining the wisdom of seasoned leaders in psychiatry residency and fellowship training with the perspective of current residents-in-training, The Psychiatry Resident Handbook offers insights and guidance readers will not easily find in any other resource.

Enlivened by detailed and engaging clinical dialogues - all based on real-world clinical practice - this book introduces the acceptance and commitment therapy (ACT) model, demonstrating how it applies to findings from crisis studies and can be integrated into clinical practice.

With examinations of 19 new psychiatric drugs, 19 new forms of previously available drugs, and a host of new medical agents, this third edition of the Clinical Manual of Psychopharmacology in the Medically Ill has been updated to include medical and psychiatric drugs that have become available since 2017.

The SCID-D is an interactive, semi-structured interview for assessing dissociative symptoms and disorders in adults and adolescents based on Dr. Steinberg's innovative Five Component Model of Dissociation Assessment (amnesia, depersonalization, derealization, identity confusion, and identity alteration).

"DSM-5-TR Clinical Cases clarifies and discusses psychiatric diagnosis with a particular focus on how diagnoses have evolved from DSM-5. Designed for teachers, students, and clinicians, this book presents a broad range of patient vignettes that cover the diagnostic waterfront. Each of the 104 cases is followed by a discussion by an expert clinician, who describes an approach to diagnosis through an exploration of psychiatric and personal history, symptom clusters, laboratory tests, and clinical ambiguities. The discussants also address the important ways in which diagnosis might be affected by such demographic issues as ethnicity, sexual orientation, and gender identity. Anyone interested in understanding the interface between disorder classification and patient diagnosis will find DSM-5-TR Clinical Cases compelling, captivating, and enlightening"--

"Offering a scientifically grounded review of the latest research complemented by practical examples, The Role of Companion Animals in the Treatment of Mental Disorders examines the existing evidence to support animal-based interventions for mental disorders as well as the risks associated with various types of programs. This robust volume features detailed discussion of topics that include human-animal interactions in specific patient populations and settings, as well as best practices for ensuring animal welfare and well-being with an emphasis on understanding applicable laws and regulations. Readers will come away with an understanding of the role that animals can play in mitigating psychiatric symptoms, engaging patients in treatment, and enhancing well-being-as well as key principles and considerations for determining whether an animal-based intervention is appropriate for a given patient"--

"The lifetime prevalence of eating disorders in the United States is approximately 0.80% for anorexia nervosa, 0.28% for bulimia nervosa, and 0.85% for binge-eating disorder, although estimates can vary depending on the study location, sample demographic characteristics, case finding, and diagnostic approaches. Importantly, the lifetime burdens and psychosocial impairments associated with an eating disorder can be substantial because these illnesses typically have an onset in adolescence or early adulthood and can persist for decades. Since publication of the previous practice guideline on eating disorders, there have been many studies on psychotherapies for individuals with these diagnoses as well as some studies on pharmacotherapies. However, substantial gaps remain in the availability and use of evidence-based treatments for individuals with an eating disorder. The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders seeks to enhance the assessment, treatment, and quality of care in adolescents, young adults, and adults with an eating disorder. The guideline focuses on evidence-based pharmacological, psychotherapeutic, and other nonpharmacological treatments for eating disorders, primarily anorexia nervosa, bulimia nervosa, and binge-eating disorder. In addition to statements related to assessment and treatment planning, which are an integral part of patient-centered care, the guideline provides direction on implementing these recommendations into clinical practice, with the goal of reducing the mortality, morbidity, and significant psychosocial and health consequences of these important psychiatric conditions"--